DEPLOY

Buying guide

Maestro

By Moon Surgical · surgical

Price
$300,000-$800,000· analyst estimate
Availability
Internal use only (not for retail).
Maturity
pilot
Real-world use
Yes, 1 verified deployment

Moon Surgical's Maestro is a laparoscopic surgical-assistant platform (it holds and positions instruments and the endoscope alongside the surgeon, not a full master-slave teleoperated replacement system) and the assistive-laparoscopy archetype of DEPLOY's surgical cluster, editorially distinct from the replacement-robotics of Intuitive, Medtronic, and CMR. Its ScoPilot software is shipped AI (NVIDIA Holoscan-powered) for intraoperative scope control. On regulatory status (a correction worth recording): the Maestro received FDA 510(k) clearance K240598 on June 5, 2024 (not December 2023), and ScoPilot was FDA-cleared in 2025 with a Predetermined Change Control Plan. As enterprise B2B surgical equipment, there is no consumer price.

Readiness

Maestro is internal use only (not for retail) at $300,000-$800,000 (analyst estimate), the 1 capability claim on file is all teleoperated-assisted with verified, 1 verified deployment is on file, and no incidents are on record.

Availability
internal-only

Internal use only (not for retail).

see evidence →

Price honesty
analyst-estimate

One price on file: $300,000-$800,000 (analyst estimate).

see evidence →

Capability honesty
teleoperated-assisted

1 reviewed claim: teleoperated-assisted, verified.

see evidence →

Real-world use
pilot

Maturity: pilot. 1 verified deployment in the registry.

see evidence →

Safety record
no-incidents

No incidents on record. 1 verified deployment on file.

What it claims to do

Price

Real-world use

Safety record

No incidents on record. 1 verified deployment on file.

Privacy

No privacy practices disclosed or on file for Maestro.

Specs

notes
  • Verified: Moon Surgical (private; Paris + San Carlos CA; CEO Anne Osdoit; board chair Fred Moll, Intuitive co-founder; backers Sofinnova + NVentures/NVIDIA) makes Maestro, a laparoscopic surgical-ASSISTANT/collaboration robot (holds/positions instruments alongside the surgeon, not a full teleop console). Commercial Maestro FDA 510(k)-cleared Jun 5 2024 (K240598); >1,100 patients treated across US + Europe (company-stated). ~$90M+ raised.
  • AI-substance: genuine SHIPPED AI (notable): ScoPilot is a genuine SHIPPED, FDA-cleared AI feature (intraoperative scope control via NVIDIA Holoscan), with a PCCP - not merely demonstrated. This distinguishes Maestro from the teleop-only platforms in this cohort. Maestro itself is a collaborative/assist robot (an honest distinction from full master-slave teleop).
  • CORRECTION (pathway): Maestro went the 510(k) route (K240598), NOT de novo (the dispatch hypothesized de novo). De novo around that time was Virtual Incision/MIRA and MMI/Symani - different companies.
  • Claimed but NOT verified: CE mark status/date (unverified this pass); exact installed-system count; the 'industry's first AI on a commercial surgical robot' superlative (marketing); the >1,100-patients figure (company-sourced).
console
not a full master-slave teleoperation console
products
Maestro: a laparoscopic surgical-assistant platform (holds/positions instruments + endoscope alongside the surgeon). ScoPilot: shipped AI software (NVIDIA Holoscan-powered) for intraoperative scope control. Commercial Maestro FDA 510(k) K240598 cleared Jun 5 2024; ScoPilot FDA-cleared 2025 with a Predetermined Change Control Plan (PCCP).
formFactor
surgical (laparoscopic surgical-assistant / collaboration robot: holds + positions instruments alongside the surgeon; not full master-slave teleop)
fda_clearance
FDA 510(k) clearance under K240598 on June 5, 2024
clearance_body
FDA
procedure_types
laparoscopic

What's under the hood

No brain on file for Maestro.

Frequently asked questions

Is the Maestro actually available for purchase?
Not available to consumers. In internal use by Moon Surgical.Source: Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)
What does the Maestro cost?
Maestro costs $300,000-$800,000 one-time (analyst estimate).Source: How Much is a Surgical Robot? (2025 Edition) – R2 Surgical
Does the Maestro really assists surgery?
Verified at teleoperator-assisted autonomy; not fully autonomous.Source: Moon Surgical receives second FDA clearance, covering its commercial Maestro Robotic Surgery System -- PR Newswire, June 2024; FDA 510(k) cleared for commercial version; CE marked September 2023; 200+ patients treated at European pilot sites
Where is the Maestro being used?
Maestro is in use at: Jacksonville (2023-09-26).Source: Moon Surgical Announces First Clinical Cases in the U.S. Using Maestro System
Is the Maestro safe?
No incidents on record across 1 verified deployment.
How does the Maestro handle privacy?
No privacy practices disclosed or on file for Maestro.
Who makes the Maestro?
Maestro is made by Moon Surgical, based in San Carlos, California, USA.Source: Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)

Video

PRIMARY SOURCE
Courtesy of Moon Surgical

Moon Surgical's overview of its Maestro surgical-assistance system. Maestro is operated by the surgical team; its ScoPilot feature automates scope and camera movement, not the surgery.

Manufacturer

Moon Surgical (registry record: /companies/moon-surgical)

Compare side by side

Sources

  1. Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024) · https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro
  2. FDA 510(k) K240598: Maestro System (cleared Jun 5 2024) · https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K240598
  3. Moon Surgical ScoPilot AI FDA clearance (with PCCP; NVIDIA Holoscan) · https://www.biospace.com/moon-surgical-scopilot-fda-nvidia-holoscan
  4. Moon Surgical raises $55.4M; Fred Moll board chair; NVentures-backed · https://www.massdevice.com/moon-surgical-funding-fred-moll/
  5. Moon Surgical receives second FDA clearance, covering its commercial Maestro Robotic Surgery System -- PR Newswire, June 2024; FDA 510(k) cleared for commercial version; CE marked September 2023; 200+ patients treated at European pilot sites · https://www.prnewswire.com/news-releases/moon-surgical-receives-second-fda-clearance-covering-its-commercial-maestro-robotic-surgery-system-302164186.html · 2024-06-05
  6. Moon Surgical official YouTube (@moonsurgical), embedded under standard YouTube embed terms. oEmbed author_url verified 2026-06-04. Maker product video; surgeon-teleoperated/assisted system, not autonomous. · https://www.youtube.com/watch?v=AuplMN-VpCU · 2026-06-04
  7. How Much is a Surgical Robot? (2025 Edition) – R2 Surgical · https://r2surgical.com/blogs/news/how-much-is-a-surgical-robot-2025-edition
  8. Moon Surgical Announces First Clinical Cases in the U.S. Using Maestro System · https://www.businesswire.com/news/home/20230926938682/en/Moon-Surgical-Announces-First-Clinical-Cases-in-the-U.S.-Using-Maestro-System · 2023-09-26
  9. First U.S. clinical cases performed with Moon Surgical's Maestro surgical robot · https://www.massdevice.com/first-cases-moon-surgical-maestro-surgical-robot/ · 2023-09-26

Recent coverage

See all coverage →


Machine-readable: this page as markdown.

Canonical: https://deploy.report/models/moon-maestro